This Study Tests Whether BI 409306 Prevents Patients With Schizophrenia From Becoming Worse. This Study Looks at How Well Patients Tolerate BI 409306 and How Effective it is Over 6 Months
Clinical trial NCT03351244 · TERMINATED
Trial details
- NCT number
- NCT03351244
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-07
- Primary completion
- 2021-03-10
- Enrollment
- 264
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.